The link to the live webcast of the Company's presentation will be available by visiting Gibraltar's website at https://ir.gibraltar1.com/reports-presentations. About Gibraltar Gibraltar is a leading manufacturer and provider of products and services for the residential, agtech, and infrastructure markets. Gibraltar's mission, to make life better for people and the planet, is fueled by advancing the disciplines of engineering, science, and technology. Gibraltar is innovating to reshape critical markets in c ...

Core Insights - BioHarvest Sciences has entered a strategic CDMO partnership with Saffron Tech to enhance the production of saffron-derived botanical compounds using its patented Botanical Synthesis technology [1][3][5] - The partnership aims to address the challenges of saffron cultivation, which is labor-intensive and geographically limited, by utilizing cell-based production methods [8][12] Company Overview - BioHarvest Sciences is a biotechnology company specializing in Botanical Synthesis, allowing for the production of plant-based compounds without the need to grow the plants themselves [13] - Saffron Tech, founded in 2020, has developed advanced cultivation methods that enable year-round production of high-quality saffron, significantly increasing yield compared to traditional methods [2][12] Partnership Details - The agreement stipulates that Saffron Tech will own 75% of the developed saffron compositions, while BioHarvest will retain 25% [4] - The collaboration will involve simultaneous development phases, which could expedite the time to market for saffron-derived products [3][7] Market Potential - Saffron is the world's most expensive spice, retailing for over $10,000 per kilogram, and is primarily sourced from Iran, which accounts for over 80% of global production [2][8] - The partnership aims to create a sustainable and controlled production alternative to meet the growing global demand for saffron-based wellness products [8][12] Financial Performance - BioHarvest's preliminary revenue for Q3 2025 is expected to be approximately $9.1 million, with an adjusted EBITDA range of ($0.7 million) to ($0.4 million) [9][11] - Guidance for Q4 2025 indicates a revenue range of $9 million to $9.5 million, with adjusted EBITDA expected to be between ($0.6 million) and $0.0 million [10][11]

Core Insights - Soybean-related stocks surged significantly following President Trump's comments regarding trade tensions with China, particularly affecting small-cap oilseed and agricultural biotech stocks [1][2]. Trade Tensions - Trump accused China of an "Economically Hostile Act" for not purchasing U.S. soybeans, which he claimed was harming American soybean farmers [2]. - He suggested the U.S. might terminate business with China related to cooking oil and other trade elements, asserting that the U.S. could produce cooking oil independently [2]. Soybean Short Squeeze - Australian Oilseeds Holdings Limited (NASDAQ:COOT) experienced a dramatic increase of nearly 350% in stock price due to the short squeeze triggered by Trump's remarks [3]. - The stock had previously faced pressure from trade tensions and compliance issues, but the combination of high short interest and Trump's comments created ideal conditions for a short squeeze [3]. Stock Performance - Origin Agritech Limited (NASDAQ:SEED) saw a 63% increase, while Arcadia Biosciences, Inc. (NASDAQ:RKDA) rose by 46% in early trading on the same day [4]. - The rally in soybean-related stocks exemplified a textbook short squeeze, where low-priced stocks with significant short interest surged due to news, forcing short sellers to buy back shares at higher prices [4].